Rici Healthcare Holdings Limited reported consolidated earnings results for the year ended December 31, 2017. For the year, revenue was RMB 1,080,149,000 against RMB 935,383,000 a year ago. Operating loss was RMB 57,672,000 against profit of RMB 90,375,000 a year ago. Loss before income tax was RMB 108,914,000 against profit of RMB 90,982,000 a year ago. Loss attributable to owners of the company was RMB 62,166,000 against profit of RMB 58,924,000 a year ago. Adjusted EBITDA for the year ended December 31, 2017 was approximately RMB 153.7 million, representing a decrease of 38.5% from approximately RMB 249.9 million in 2016. Loss per share for loss attributable to owners of the company – basic and diluted was RMB 0.04 against earnings of RMB 0.04 a year ago. Net cash generated from operating activities was RMB 27,280,000 against RMB 173,283,000 a year ago. The Group incurred capital expenditure of RMB 479.8 million, primarily due to purchases of medical equipment for new medical examination centers and specialty hospitals.